Modern Chinese Medicine Group Co., Ltd. (HKG:1643)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.9900
+0.0200 (2.06%)
Jul 31, 2026, 3:44 PM HKT

HKG:1643 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
145.17145.17214.07344.08399.66360.7
Revenue Growth
-28.20%-32.18%-37.78%-13.91%10.80%16.85%
Gross Profit
23.5623.5655.2104.18170.79158.43
Operating Income
-16.54-16.5423.8368.37129.1113.64
Net Income
-13.56-13.569.6748.887.8381.78
Earnings Per Share
-0.02-0.020.020.080.150.14
EPS Growth
---80.18%-44.44%6.30%-2.53%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
229.71229.71229.67286.27282.26176.09
Total Debt
0.070.070.140.070.390.41
Net Cash (Debt)
229.64229.64229.53286.19281.86175.68
Net Cash Growth
-18.89%0.05%-19.80%1.54%60.44%159.68%
Net Cash Per Share
0.350.350.380.480.470.30

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4.274.2758.988.48125.7957.6
Capital Expenditures
-22-22-114.3-5.1-11.72-69.98
Free Cash Flow
-17.73-17.73-55.323.38114.06-12.38
Free Cash Flow Growth
----97.04%--

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
16.23%16.23%25.79%30.28%42.73%43.92%
Operating Margin
-11.39%-11.39%11.13%19.87%32.30%31.51%
Pretax Margin
-9.66%-9.66%6.92%19.85%31.11%31.67%
Profit Margin
-9.34%-9.34%4.52%14.18%21.98%22.67%
FCF Margin
-12.21%-12.21%-25.84%0.98%28.54%-3.43%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
--21.873.803.324.90
P/FCF Ratio
---54.822.56-
PS Ratio
4.412.270.990.540.731.11